GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human ppargamma ligand binding domain in complex with SR16832

Analyse Crystal structure of human ppargamma ligand binding domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6AUG
Type
protein
Length
522 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
BXG, KNA
Pockets
7 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 65% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein26067% helix, 4% strandP37231
BPeroxisome proliferator-activated receptor gammaprotein26262% helix, 5% strandP37231

Ligands and binding sites

  • BXG · 2-chloro-N-(6-methoxyquinolin-4-yl)-5-nitrobenzamide · ligand · 2 copies · chains A, B
  • KNA · nonanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14870.840.9055BXG
23950.780.8754BXG, KNA
33360.610.7837empty
43560.600.7726empty
51790.590.8124empty

Interfaces

1 interface between chains.

  • A–B · 977 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 6AUG · Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with SR16832 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.